Phase 3 Myeloproliferative Neoplasm Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
Beta-ThalassemiaMyelodysplastic Syndromes (MDS)Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
Celgene665 enrolled143 locationsNCT04064060
Recruiting
Phase 3
P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk
Myeloproliferative NeoplasmPrimary Myelofibrosis
PharmaEssentia150 enrolled1 locationNCT06468033
Recruiting
Phase 3
Long-term Efficacy of Once Daily Versus Twice Daily Aspirin in High-risk MPN Patients With Aspirin Resistance
Myeloproliferative Neoplasms (MPN)
Siriraj Hospital240 enrolled1 locationNCT06740916